首页> 外文OA文献 >Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

【2h】

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

机译：复发无关的进展对复发相关的贡献与总体证实的残疾积累典型复发多发性硬化累计2次随机临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ludwig Kappos; Jerry S. Wolinsky; Gavin Giovannoni; Douglas L. Arnold; Qing Wang; Corrado Bernasconi; Fabian Model; Harold Koendgen; Marianna Manfrini; Shibeshih Belachew; Stephen L. Hauser;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials [J] . Scott Thomas, Wang Ping, You Xiaojun, Neuroepidemiology . 2015,第1期

机译：复发-缓解型多发性硬化症中持续残疾进展与功能系统评分之间的关系：来自四个随机临床试验的安慰剂数据分析
2. A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients [J] . Mehrdokht Mazdeh, Shahriar Kargar Monhaser, Mohammad Taheri, Clinical and Translational Medicine . 2019,第1期

机译：一项非随机临床试验，用于评估芬戈莫德对复发缓解型多发性硬化症患者的扩展残疾状态量表评分和复发次数的影响
3. Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials [J] . Amy M.Lavery, Leonard H.Verhey, Amy T.Waldman Multiple Sclerosis International . 2014,第3期

机译：复发-缓解型多发性硬化的结果指标：在临床试验中捕获残疾和疾病进展
4. Contributions to analysis of randomized multi-center clinical trials: The role of conditioning. [D] . Zheng, Lu. 2005

机译：对随机多中心临床试验分析的贡献：调节作用。
5. A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients [O] . Mehrdokht Mazdeh, Shahriar Kargar Monhaser, Mohammad Taheri, 2019

机译：一项非随机临床试验用于评估芬戈莫德对复发缓解型多发性硬化症患者的扩展残疾状态量表评分和复发次数的影响
6. Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis [O] . G. Giovannoni, L. Kappos, S.L. Hauser, 2019

机译：复发率的长期减少复发率和确认的残疾进展在复发多发性硬化症的患者中ocrelizumab治疗后

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

著录项

引文网络

相似文献

相关主题

期刊订阅